A BILL 
To require the head of each Federal agency, within 100 
calendar days, to complete all pending Freedom of Infor-
mation Act requests related to a drug or medical device 
to prevent, diagnose, mitigate, or treat COVID–19, gain- 
of-function or potential pandemic pathogen research, or 
a policy, rule, or standard requiring COVID–19 vaccina-
tion of individuals, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
17:11 Dec 23, 2021
H6321
2 
•HR 6321 IH
SECTION 1. SHORT TITLE. 
1
This Act may be cited as the ‘‘Answer COVID FOIAs 
2
Now Act’’. 
3
SEC. 2. COMPLETION OF FOIA REQUESTS RELATING TO 
4
DRUGS AND MEDICAL DEVICES TO PREVENT, 
5
DIAGNOSE, MITIGATE, OR TREAT COVID–19. 
6
(a) IN GENERAL.— 
7
(1) COMPLETION
OF
REQUESTS.—Notwith-
8
standing any other provision of law, the head of each 
9
Federal agency shall, not later than 100 calendar 
10
days after the date of enactment of this Act, com-
11
plete all requests for records made under section 
12
552(a) of title 5, United States Code, that are— 
13
(A) made to the Federal agency; 
14
(B) pending as of the date of enactment of 
15
this Act; and 
16
(C) related to— 
17
(i) a drug or medical device to pre-
18
vent, diagnose, mitigate, or treat COVID– 
19
19; 
20
(ii) gain-of-function research or poten-
21
tial pandemic pathogen research; or 
22
(iii) a policy, rule, or standard requir-
23
ing COVID–19 vaccination of individuals. 
24
(2) RULE OF CONSTRUCTION.—Nothing in this 
25
Act shall be construed to require the disclosure of 
26
17:11 Dec 23, 2021
H6321
3 
•HR 6321 IH
information that is exempt from disclosure under 
1
section 552(b) of title 5, United States Code. 
2
(b) LIST OF PENDING REQUESTS.—The head of a 
3
Federal agency shall publicly and electronically make 
4
available a list of all requests described in subsection 
5
(a)(1). 
6
(c) REPORTS.— 
7
(1) INITIAL REPORT.—Not later than 7 busi-
8
ness days after the date of enactment of this Act, 
9
the head of each Federal agency shall provide the 
10
list required by subsection (b) to— 
11
(A) the Committee on the Judiciary, the 
12
Committee on Energy and Commerce, and the 
13
Committee on Oversight and Reform of the 
14
House of Representatives; 
15
(B) the Committee on the Judiciary, the 
16
Committee on Health, Education, Labor, and 
17
Pensions, and the Committee on Homeland Se-
18
curity and Governmental Affairs of the Senate; 
19
and 
20
(C) the Secretary of the Treasury. 
21
(2) SUBSEQUENT REPORT.—Not later than 100 
22
calendar days after the date of enactment of this 
23
Act, the head of each Federal agency shall provide 
24
17:11 Dec 23, 2021
H6321
4 
•HR 6321 IH
a list of all requests described in subsection (a)(1) 
1
that remain pending, if any, to— 
2
(A) the committees referred to in para-
3
graph (1); and 
4
(B) the Secretary of the Treasury. 
5
(d) DEFINITIONS.—In this section: 
6
(1) The term ‘‘Federal agency’’ means an agen-
7
cy as that term is defined in section 551 of title 5, 
8
United States Code. 
9
(2) The term ‘‘gain-of-function research’’ means 
10
any research that may be reasonably anticipated to 
11
confer an attribute to a pathogen such that the 
12
pathogen would have enhanced pathogenicity or 
13
transmissibility in mammals. 
14
(3) The term ‘‘potential pandemic pathogen’’ 
15
means a pathogen that, prior to any gain-of-function 
16
research— 
17
(A) is likely highly transmissible and likely 
18
capable of wide and uncontrollable spread in 
19
human populations; and 
20
(B) is likely highly virulent and likely to 
21
cause significant morbidity or mortality in hu-
22
mans. 
23
17:11 Dec 23, 2021
H6321
5 
•HR 6321 IH
SEC. 3. PENALTY FOR FAILURE TO DISPOSE OF PENDING 
1
FOIA REQUESTS. 
2
Beginning on the day that is 101 calendar days after 
3
the date of enactment of this Act, the Secretary of the 
4
Treasury shall transfer from the appropriations account 
5
of the office of the head of a Federal agency (as defined 
6
in section 2(d)) to the Countermeasures Injury Compensa-
7
tion Program of the Health Resources and Services Ad-
8
ministration $1,000,000 for each calendar day on which 
9
any request described in section 2(a)(1) remains pending 
10
with such Federal agency. 
11
SEC. 4. COMPELLING NEED FOR EXPEDITED PROCESSING. 
12
With respect to affirming or denying a request for 
13
expedited 
processing 
of 
a 
record 
under 
section 
14
552(a)(6)(E) of title 5, United States Code, a person sub-
15
mitting such request to a Federal agency (as defined in 
16
section 2(d)) shall be deemed to have demonstrated a com-
17
pelling need for such record if such record is related to— 
18
(1) a drug or medical device to prevent, diag-
19
nose, mitigate, or treat COVID–19; 
20
(2) gain-of-function research or potential pan-
21
demic pathogen research (as such terms are defined 
22
in section 2(e)); or 
23
(3) a policy, rule, or standard requiring 
24
COVID–19 vaccination of individuals. 
25
Æ 
17:11 Dec 23, 2021
H6321
